Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
72
CING Quote, Financials, Valuation and Earnings
Last price:
$8.59
Seasonality move
:
-12.58%
Day range:
$7.83 - $8.85
52-week range:
$3.20 - $9.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
19.55x
Volume:
688K
Avg. volume:
367.4K
1-year change:
132.51%
Market cap:
$67.9M
Revenue:
--
EPS (TTM):
-$5.29
Analysts' Opinion
-
Consensus RatingCingulate, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $27.77, Cingulate, Inc. has an estimated upside of 204.52% from its current price of $8.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing 100% downside risk from its current price of $8.51.
Fair Value
-
According to the consensus of 2 analysts, Cingulate, Inc. has 204.52% upside to fair value with a price target of $27.77 per share.
CING vs. S&P 500
-
Over the past 5 trading days, Cingulate, Inc. has overperformed the S&P 500 by 38.29% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cingulate, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cingulate, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Cingulate, Inc. reported revenues of --.
Earnings Growth
-
Cingulate, Inc. has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Cingulate, Inc. reported earnings per share of -$1.35.
Enterprise value:
66.4M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-3.70x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$579.4K
Return On Assets:
-169.99%
Net Income Margin (TTM):
--
Return On Equity:
-320.62%
Return On Invested Capital:
-197.06%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$560.5K | -$665.1K | -$579.4K | -$165.4K | -$106.8K | |
| Operating Income | -$20.4M | -$16.2M | -$20.6M | -$3.3M | -$6M | |
| EBITDA | -$19.9M | -$15.6M | -$20M | -$3.1M | -$5.9M | |
| Diluted EPS | -$391.09 | -$86.30 | -$5.29 | -$2.34 | -$1.35 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.6M | $11.8M | $2.9M | $11.3M | $7.4M | |
| Total Assets | $9.1M | $15.4M | $5.9M | $13.6M | $10.5M | |
| Current Liabilities | $5.1M | $6.4M | $5.7M | $1.5M | $5.9M | |
| Total Liabilities | $6M | $7M | $6M | $1.5M | $7M | |
| Total Equity | $3.1M | $8.4M | -$96.3K | $12M | $3.5M | |
| Total Debt | -- | $619.9K | $251K | $8.8K | $4.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$16.7M | -$16.9M | -$17.7M | -$3.9M | -$4.2M | |
| Cash From Investing | -$180.2K | -$200.3K | -$204.4K | $140.8K | -- | |
| Cash From Financing | $9M | $25.2M | $14M | $13.4M | $1.5M | |
| Free Cash Flow | -$16.9M | -$17.1M | -$17.9M | -$3.7M | -$4.2M | |
CING
Sector
Market Cap
$67.9M
$25.3M
Price % of 52-Week High
96.71%
48.74%
Dividend Yield
0%
0%
Shareholder Yield
-42.27%
-1.64%
1-Year Price Total Return
138.74%
-19.12%
Beta (5-Year)
--
0.492
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$6.97
200-day SMA
Buy
Level
$4.54
Bollinger Bands (100)
Buy
Level
3.57 - 6.09
Chaikin Money Flow
Buy
Level
583.1K
20-day SMA
Buy
Level
$6.53
Relative Strength Index (RSI14)
Buy
Level
71.75
ADX Line
Buy
Level
26.89
Williams %R
Sell
Level
-8.4239
50-day SMA
Buy
Level
$5.88
MACD (12, 26)
Buy
Level
0.94
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
1.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-11.7122)
Sell
CA Score
(Annual)
Level (-10.2995)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (9.6167)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.
Stock Forecast FAQ
In the current month, CING has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CING average analyst price target in the past 3 months is $27.77.
-
Where Will Cingulate, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cingulate, Inc. share price will rise to $27.77 per share over the next 12 months.
-
What Do Analysts Say About Cingulate, Inc.?
Analysts are divided on their view about Cingulate, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cingulate, Inc. is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Cingulate, Inc.'s Price Target?
The price target for Cingulate, Inc. over the next 1-year time period is forecast to be $27.77 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CING A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cingulate, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CING?
You can purchase shares of Cingulate, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cingulate, Inc. shares.
-
What Is The Cingulate, Inc. Share Price Today?
Cingulate, Inc. was last trading at $8.59 per share. This represents the most recent stock quote for Cingulate, Inc.. Yesterday, Cingulate, Inc. closed at $8.51 per share.
-
How To Buy Cingulate, Inc. Stock Online?
In order to purchase Cingulate, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CING Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CING
Sector
P/E ratio
--
21.47x
PEG ratio
--
-0.01x
P/B ratio
19.55x
1.74x
Price / LTM sales
--
1.45x
Growth Metrics
CING
Sector
Revenue growth
--
3.36%
Earnings growth
42.13%
11.93%
Revenue (5-year growth)
--
6.25%
Earnings forecast
-$1.55
-$0.20
Profitability
CING
Sector
Profitability FY 2024
-$653.1K
$2.2M
Return on invested capital
-197.06%
-33.31%
Return on assets
-169.99%
-29.82%
Return on equity
-320.62%
-40.01%
Earnings Date
Last Earnings Date
Mar
13
Next Earnings Date
Mar
13
Estimated Next Earnings Date
Jun
12
Balance Sheet
CING
Sector
Total cash
$6.1M
$24.9M
Short term investments
--
$23.2M
Total assets
$14.9M
$69.8M
Long term debt
$4.3M
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
52
PZZA alert for Mar 13
Papa John's International, Inc. [PZZA] is down 6.61% over the past day.
Buy
53
NBIS alert for Mar 13
Nebius Group NV [NBIS] is up 0.3% over the past day.
Buy
88
NBTX alert for Mar 13
Nanobiotix SA [NBTX] is down 1.41% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
